Amgen Denosumab Data Positive On Bone Mineral Density In Women
This article was originally published in The Pink Sheet Daily
Executive Summary
Infections, neoplasms seen in treatment group; more data due by year end.
You may also be interested in...
Amgen’s Positive Denosumab Pivotal Trial Reduces Overhangs For Firm
Big biotech needs the potential $2.4 billion analysts estimate the bone-building drug could bring by 2016.
Amgen’s Positive Denosumab Pivotal Trial Reduces Overhangs For Firm
Big biotech needs the potential $2.4 billion analysts estimate the bone-building drug could bring by 2016.
ASCO Early Release Offers Highlights, But The Best Is Yet To Come
Part one of “The Pink Sheet” DAILY’s review of roughly 5,000 abstracts released ahead of the American Society of Clinical Oncology annual meeting.